Literature DB >> 29793582

Cardiac troponin I as an early prognosis biomarker after trauma: a retrospective cohort study.

M Decavèle1, N Gault2, T Gauss3, S Pease3, J D Moyer3, C Paugam-Burtz3, A Foucrier3.   

Abstract

BACKGROUND: The significance of cardiac troponin I (cTnI) elevation after trauma is debated. We therefore explored the association between cTnI elevation at admission after trauma and ICU mortality.
METHODS: We performed a retrospective analysis from a prospectively constituted database, of patients admitted to ICU after trauma at a single centre, over a 36 month period. According to cTnI plasma concentration at admission, patients were categorised into three groups: normal (<0.05 ng ml-1), intermediate (0.05-0.99 ng ml-1), or high concentration (≥1.0 ng ml-1). Associations of pre-hospital conditions or cTnI elevation and mortality were analysed by multivariate logistic regression.
RESULTS: Among the 994 patients, 177 (18%) had cTnI elevation at ICU admission. Of this total, 114 (11%) patients died in the ICU. The cTnI release was an independent predictor of ICU mortality with a concentration-response relationship [odds ratio (OR) 4.90 (2.19-11.16) and 14.83 (4.68-49.90) for intermediate and high concentrations, respectively] and Day 2 mortality [OR 2.23 (1.18-5.80) and 7.49 (2.77-20.12) for intermediate and high concentrations, respectively]. The severity of thoracic trauma [OR 2.25 (1.07-4.55) and 3.23 (2.00-5.27) for Abbreviated Injury Scale scores 1-2 and ≥3, respectively], out-of-hospital maximal heart rate ≥120 beats min-1 [OR 2.22 (1.32-3.69)], and out-of-hospital shock [OR 2.02 (1.20-3.38)] were independently associated with cTnI elevation.
CONCLUSIONS: Release of cTnI was an independent predictor of ICU mortality, suggesting that this biomarker can be used in daily practice for early stratification of the risk of ICU death. Thoracic trauma was strongly associated with cTnI elevation.
Copyright © 2018 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  prognosis; trauma; troponin

Mesh:

Substances:

Year:  2018        PMID: 29793582     DOI: 10.1016/j.bja.2018.03.010

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  7 in total

1.  Changes and significance of serum troponin in trauma patients: A retrospective study in a level I trauma center.

Authors:  Li-Wen Dou; Zhe Du; Ji-Hong Zhu; Tian-Bing Wang
Journal:  World J Emerg Med       Date:  2022

2.  Management of Thoracic and Cardiac Trauma: A Case Series and Literature Review.

Authors:  Akshay Kumar; Nimisha Shiwalkar; Sameer Bhate; Suresh Keshavamurthy
Journal:  Cureus       Date:  2022-06-30

Review 3.  Electroanalytical point-of-care detection of gold standard and emerging cardiac biomarkers for stratification and monitoring in intensive care medicine - a review.

Authors:  Robert D Crapnell; Nina C Dempsey; Evelyn Sigley; Ascanio Tridente; Craig E Banks
Journal:  Mikrochim Acta       Date:  2022-03-12       Impact factor: 6.408

4.  Structural alterations and inflammation in the heart after multiple trauma followed by reamed versus non-reamed femoral nailing.

Authors:  Meike Baur; Birte Weber; Ina Lackner; Florian Gebhard; Roman Pfeifer; Paolo Cinelli; Sascha Halvachizadeh; Michel Teuben; Miriam Lipiski; Nikola Cesarovic; Hans-Christoph Pape; Miriam Kalbitz
Journal:  PLoS One       Date:  2020-06-25       Impact factor: 3.240

5.  Significance of Cardiac Troponin I Elevation in Traumatic Brain Injury Patients.

Authors:  Siamak Rimaz; Ali Ashraf; Shideh Marzban; Mohammad Haghighi; Seyyed Mahdi Zia Ziabari; Gelareh Biazar; Sheyda Rimaz; Samad Omidi
Journal:  Anesth Pain Med       Date:  2019-04-28

6.  Development of a Nomogram Model to Predict in-Hospital Survival in Patients with Multiple Trauma.

Authors:  Lin Ling; Wenchao Zhang; Qing Peng; Jing Tong
Journal:  Comput Math Methods Med       Date:  2022-08-08       Impact factor: 2.809

Review 7.  The role of antibody-based troponin detection in cardiovascular disease: A critical assessment.

Authors:  Hui Ma; Arabelle Cassedy; Richard O'Kennedy
Journal:  J Immunol Methods       Date:  2021-07-28       Impact factor: 2.303

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.